The fellowship is a tailored training opportunity intended to train a pathogen genomics and bioinformatics workforce with expertise to improve outbreak detection and disease surveillance in Africa.
The fellowship program offers a competency-based core curriculum providing the opportunity to standardize processes while also supporting fellows to gain an in-depth understanding of core thematic areas. The program will allow immersion in work settings beyond SARS-CoV-2 genomic surveillance.
It will additionally provide opportunities for an alumni network that includes the chance to stay in contact and continue to learn from each as well as create professional relationships between the fellows and their mentors, hence fostering future collaborative opportunities.
The fellowship is a twelve-week program designed to promote fellowship recipients career development and foster collaboration between institutions in different countries.
Fellows will be trained in one of two tracks:
Next-generation sequencing (NGS); and basic public health bioinformatics and data analytics.
Fellows will obtain tailored training and experience through a standardized approach based on partnership with selected Centers of Excellence in pathogen genomics and bioinformatics across Africa.
Up to 25 fellowships may be awarded each year to fellows from national public health institutions and national reference laboratories in Africa.
Submission: Applications must be submitted by completing the online application forms:
- Application form - English - https://bit.ly/3ztLuaQ
- Application form - French - https://bit.ly/3KqnQ5o
More details on the fellowship program
Application due date: 28 April 2023
Information sessions for potential fellows at CERI & KRISP & Africa CDC fellowship program:
- 12 April 2023 (CERI & KRISP information section, see @tuliodna, @ceri_news & @krisp_news for details)
- 18 April 2023 (Africa CDC information section, see @AfricaCDC twitter for details)
News date: 2023-04-28
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).